Daily Roundup

Monday, 24th November 2025
Last updated: 21:00

← Friday, 21st November 2025

PME.ASX IRI.ASX BHP.ASX M7T.ASX EZL.ASX

A Busy Day for Australia's Top Companies

Pro Medicus Limited has been on a roll, signing three new contracts worth a combined minimum of A$29 million. The deals cover a diverse range of customers, from a children's hospital to a cancer center and a physician-owned regional healthcare provider. CEO Dr. Sam Hupert says this reinforces the company's belief that its cloud-based, transaction-based products are well-suited for virtually all segments of the market.

But that's not all for Pro Medicus. The company has just delivered another record year, with revenue up 31.9% to $213 million and net profit after tax up 39.2% to $115.2 million. They announced 7 new contract wins in North America totaling A$520 million, 2 large contract renewals worth A$130 million, and upgrades for additional products worth A$39 million. The board is confident FY26 will be another strong year, with performance so far ahead of budget.

Integrated Research (IR), the leading global provider of user experience and performance management solutions, has reset its strategy to focus on product-led growth. The company is investing significantly in new products to drive sustainable revenue growth over the medium term, though this is expected to reduce profits in the short to medium term. Key new releases include Prognosis Elevate, a Prognosis-as-a-Service offering, and Iris, an AI-powered Prognosis assistant.

In other news, BHP Group Limited has confirmed it is no longer considering a combination with Anglo American plc, despite believing the deal would have created significant value. BHP remains confident in its own organic growth strategy.

Finally, Mach7 Technologies Ltd has responded to an ASX price query, confirming it is unaware of any undisclosed positive information that could explain the recent increase in its share price and trading volume. The company is complying with all Listing Rules.

Overall, it's been a busy day for some of Australia's top companies, with a mix of new contract wins, strong financial results, strategic shifts, and regulatory updates. The market seems to be responding positively to these developments.